Travere Therapeutics to Report First Quarter 2021 Financial Results
Travere Therapeutics (NASDAQ: TVTX) will announce its Q1 2021 financial results on May 6, 2021, after U.S. market close. A conference call is scheduled for the same day at 4:30 p.m. ET, aimed at discussing the results and providing a business update. Interested participants can join via dial-in or a live webcast on Travere's investor relations site. A replay will be accessible from 7:30 p.m. ET on May 6 to 7:30 p.m. ET on May 13.
- None.
- None.
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced it will report first quarter 2021 financial results on Thursday, May 6, 2021 after the close of the U.S. financial markets. The Company will host a conference call and webcast to discuss the financial results and provide a general business update at 4:30 p.m. ET.
Conference Call Information
| Date: | Thursday, May 6, 2021 |
| Time: | 4:30 p.m. ET |
| Dial-in numbers: | +1 (800) 773-2954 (U.S.) or +1 (847) 413-3731 (International) |
| Confirmation code: | 50155370 |
| Live webcast: | Travere.com in the “Events & Presentations” section of the “Investors” page |
A replay of the call will be available from 7:30 p.m. ET, May 6, 2021 to 7:30 p.m. ET, May 13, 2021. The replay number is +1 (855) 859-2056 (U.S.) or +1 (404) 537-3406 (International), confirmation code 50155370.
About Travere Therapeutics
At Travere Therapeutics we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit travere.com
Contact:
Chris Cline, CFA
Senior Vice President, Investor Relations & Corporate Communications
888-969-7879
IR@travere.com
FAQ
When will Travere Therapeutics report its Q1 2021 financial results?
What time is the conference call for Travere Therapeutics Q1 results?
How can I access the Travere Therapeutics conference call?
What is the confirmation code for the Travere Therapeutics conference call?
Is there a replay available for the conference call?
